$96.50
1.51.58%
Pre-Market: May 3, 9:29 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Cosmo Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.